Skip to main content
Year archive

Verona Pharma plc — 2020 filings

All 94 regulatory filings released by Verona Pharma plc (VRNA) in 2020, sourced directly from the official regulator.

94 Filings
2020 Period
2020 filings (94)
Filing Released Lang
FORM 6-K
Foreign Filer Report
2020-12-30 English
FORM 6-K
Foreign Filer Report
2020-11-24 English
Verona Pharma Secures up to $30 Million Debt Financing from Silicon Valley Bank
Capital/Financing Update
2020-11-23 English
6-K
Foreign Filer Report
2020-11-12 English
Verona Pharma Announces November 2020 Virtual Investor Conference Participation
Investor Presentation
2020-11-09 English
6-K
Foreign Filer Report
2020-10-29 English
Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020
Earnings Release 9M 2020
2020-10-29 English
Verona Pharma plc : Update on AIM Delisting
Delisting Announcement
2020-10-28 English
Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update
Report Publication Announcement
2020-10-22 English
Verona Pharma to Present Phase 2b COPD Symptom and Quality of Life Data with Ensifentrine at CHEST 2020
Regulatory Filings
2020-10-13 English
SC 13D/A
Major Shareholding Notification
2020-10-05 English
6-K
Foreign Filer Report
2020-09-25 English
Verona Pharma Initiates Phase 3 Clinical Trials with Nebulized Ensifentrine for the Maintenance Treatment of COPD
Regulatory Filings
2020-09-23 English
6-K
Foreign Filer Report
2020-09-22 English
Intended Delisting and Cancellation of Ordinary Shares from Trading on AIM
Delisting Announcement
2020-09-21 English
Verona Pharma to Ring the Nasdaq Closing Bell to celebrate $200 million financing
Regulatory Filings
2020-09-17 English
Verona Pharma Announces Publication of Phase 2b COPD Symptom Data in the International Journal of Chronic Obstructive Pulmonary Disease
Regulatory Filings
2020-09-16 English
6-K
Foreign Filer Report
2020-09-14 English
Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
Regulatory Filings
2020-09-08 English
Verona Pharma to Present at H.C. Wainwright 22nd Annual Global Virtual Investment Conference
Investor Presentation
2020-09-02 English
Regulatory Filings 2020
Regulatory Filings
2020-08-28 English
6-K
Foreign Filer Report
2020-08-27 English
Verona Pharma plc: Grant of RADSUs and PDMR Dealings
Director's Dealing
2020-08-26 English
Regulatory Filings 2020
Regulatory Filings
2020-08-25 English
F-1/A
Regulatory Filings
2020-08-25 English
FORM 6-K/A
Foreign Filer Report
2020-08-25 English
Regulatory Filings 2020
Regulatory Filings
2020-08-24 English
Verona Pharma to Present Phase 2b data with Ensifentrine in COPD at the European Respiratory Society International Congress 2020
Regulatory Filings
2020-08-24 English
FORM S-8
Registration Form
2020-08-20 English
6-K
Foreign Filer Report
2020-08-19 English
Verona Pharma Initiates Multiple Dose Part of Phase 2 Clinical Trial with pMDI Formulation of Ensifentrine in COPD
Regulatory Filings
2020-08-19 English
F-1
Regulatory Filings
2020-08-17 English
6-K
Foreign Filer Report
2020-08-14 English
Second Price Monitoring Extn
Regulatory Filings
2020-08-14 English
Price Monitoring Extension
Regulatory Filings
2020-08-14 English
Verona Pharma plc Operational Update and Financial Results for the Three and Six Months Ended June 30, 2020
Earnings Release H1 2020
2020-08-14 English
6-K
Foreign Filer Report
2020-08-10 English
Verona Pharma plc: TR-1: Standard form for notification of major holdings
Major Shareholding Notification
2020-08-07 English
Verona Pharma plc: Issue of Equity, PDMR Dealings & Total Voting Rights
Director's Dealing
2020-08-04 English
GROWTH EQUITY OPPORTUNITIES FUND IV, LLC / VERONA PHARMA PLC -- SCHEDULE 13DA (#
Major Shareholding Notification
2020-08-03 English
Verona Pharma Announces August 2020 Virtual Investor Conference Participation
Investor Presentation
2020-08-03 English
VERONA PHARMA PLC AMENDMENT NO. 1
Major Shareholding Notification
2020-07-31 English
Verona Pharma plc: TR-1: Standard form for notification of major holdings
Major Shareholding Notification
2020-07-30 English
Verona Pharma to Announce Interim Results for the Three and Six Months Ended June 30, 2020 and Provide Corporate Update
Report Publication Announcement
2020-07-30 English
Regulatory Filings 2020
Regulatory Filings
2020-07-29 English
Verona Pharma plc: TR-1: Standard form for notification of major holdings
Major Shareholding Notification
2020-07-27 English
SC 13G
Major Shareholding Notification
2020-07-24 English
AMENDMENT NO. 1 TO SCHEDULE 13D
Major Shareholding Notification
2020-07-24 English
AMENDMENT NO. 1 TO SCHEDULE 13G
Major Shareholding Notification
2020-07-24 English
FORM 6-K
Foreign Filer Report
2020-07-22 English
Closing of Financing, Issued Share Capital and Total Voting Rights
Capital/Financing Update
2020-07-22 English
FORM 6-K
Foreign Filer Report
2020-07-18 English
Verona Pharma plc: PDMR Dealings
Director's Dealing
2020-07-17 English
Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
Capital/Financing Update
2020-07-17 English
FORM 20-F/A
Annual Report FY 2019
2020-07-16 English
Verona Pharma plc: Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2020-07-06 English
6-K
Foreign Filer Report
2020-05-14 English
Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANCE Clinical Program
Regulatory Filings
2020-05-14 English
Director/PDMR Shareholding - Grant of Restricted Stock Units, Issue of Equity, Total Voting Rights & PDMR Dealings
Director's Dealing
2020-05-12 English
Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International Conference
Regulatory Filings
2020-05-01 English
FORM S-8
Registration Form
2020-04-30 English
6-K
Foreign Filer Report
2020-04-30 English
Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020
Earnings Release Q1 2020
2020-04-30 English
Verona Pharma to Announce Financial Results for the Three Months Ended March 31, 2020 and Provide Corporate Update
Report Publication Announcement
2020-04-23 English
6-K
Foreign Filer Report
2020-04-16 English
Verona Pharma plc: Results of AGM
Declaration of Voting Results & Voting Rights Announcements
2020-04-16 English
6-K
Foreign Filer Report
2020-04-14 English
Update on AGM Procedure
AGM Information
2020-04-08 English
6-K
Foreign Filer Report
2020-04-06 English
Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD
Earnings Release Q1 2020
2020-03-31 English
6-K
Foreign Filer Report
2020-03-30 English
6-K
Foreign Filer Report
2020-03-30 English
Verona Pharma plc: Issue of Equity and Total Voting Rights
Share Issue/Capital Change
2020-03-20 English
Second Price Monitoring Extn
Regulatory Filings
2020-03-17 English
Price Monitoring Extension
Regulatory Filings
2020-03-17 English
2019 Annual Report and Accounts and Notice of AGM
Report Publication Announcement
2020-03-16 English
6-K
Foreign Filer Report
2020-03-10 English
Grant of Restricted Stock Units and PDMR Dealings
Director's Dealing
2020-03-05 English
20-F
Annual Report FY 2019
2020-02-27 English
Verona Pharma Reports Financial Results for the Full Year Ended December 31, 2019 and Provides Corporate Update
Report Publication Announcement
2020-02-27 English
Verona Pharma plc to Announce Financial Results for Full Year Ended December 31, 2019 and Provide Corporate Update
Report Publication Announcement
2020-02-21 English
Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory Research
Regulatory Filings
2020-02-14 English
Holding(s) in Company TR-1: Standard form for notification of major holdings
Major Shareholding Notification
2020-02-07 English
SC 13G/A
Major Shareholding Notification
2020-02-05 English
6-K
Foreign Filer Report
2020-02-04 English
Verona Pharma Announces Senior Management Changes
Board/Management Information
2020-02-03 English
Verona Pharma to Present at LSX World Congress 2020
Investor Presentation
2020-01-28 English
Holding(s) in Company TR-1: Standard form for notification of major holdings
Major Shareholding Notification
2020-01-17 English
6-K
Foreign Filer Report
2020-01-17 English
Second Price Monitoring Extn
Regulatory Filings
2020-01-13 English
Price Monitoring Extension
Regulatory Filings
2020-01-13 English
Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy
Earnings Release Q1 2020
2020-01-13 English
Verona Pharma to Report 4 Week Phase 2b COPD Dose-ranging Study Results with Nebulized Ensifentrine on Top of Tiotropium Therapy
Earnings Release FY 2019
2020-01-11 English
Verona Pharma Appoints David Moskowitz as Vice President, Capital Markets Strategy & Investor Relations
Board/Management Information
2020-01-07 English